Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Differential Virtual Screening (DVS) with Active and Inactive Molecular Models for Finding and Profiling GPCR Modulators: Case of the CCK1 Receptor.

Diaz C, Leplatois P, Angelloz-Nicoud P, Lecomte M, Josse A, Delpech M, Pecceu F, Loison G, Shire D, Pascal M, Ferrara P, Ferran E.

Mol Inform. 2011 Apr 18;30(4):345-58. doi: 10.1002/minf.201000180. Epub 2011 Apr 1.

PMID:
27466951
2.

An antagonistic monoclonal antibody (B-N6) specific for the human neurotensin receptor-1.

Ovigne JM, Vermot-Desroches C, Lecron JC, Portier M, Lupker J, Pecceu F, Wijdenes J.

Neuropeptides. 1998 Jun;32(3):247-56.

PMID:
10189059
3.

SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.

Portier M, Rinaldi-Carmona M, Pecceu F, Combes T, Poinot-Chazel C, Calandra B, Barth F, le Fur G, Casellas P.

J Pharmacol Exp Ther. 1999 Feb;288(2):582-9.

PMID:
9918562
4.

A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions.

Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, Maffrand JP, Le Fur G, Casellas P.

J Biol Chem. 1997 Aug 29;272(35):22330-9.

5.

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.

Gully D, Labeeuw B, Boigegrain R, Oury-Donat F, Bachy A, Poncelet M, Steinberg R, Suaud-Chagny MF, Santucci V, Vita N, Pecceu F, Labbé-Jullié C, Kitabgi P, Soubrié P, Le Fur G, Maffrand JP.

J Pharmacol Exp Ther. 1997 Feb;280(2):802-12.

PMID:
9023294
6.

Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24.

Poinot-Chazel C, Portier M, Bouaboula M, Vita N, Pecceu F, Gully D, Monroe JG, Maffrand JP, Le Fur G, Casellas P.

Biochem J. 1996 Nov 15;320 ( Pt 1):145-51.

7.

Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin-13.

Lebel-Binay S, Laguerre B, Quintin-Colonna F, Conjeaud H, Magazin M, Miloux B, Pecceu F, Caput D, Ferrara P, Fradelizi D.

Eur J Immunol. 1995 Aug;25(8):2340-8.

PMID:
7664796
8.

Human interleukin 1 beta fused to the human growth hormone signal peptide is N-glycosylated and secreted by Chinese hamster ovary cells.

Pecceu F, Dousset P, Shire D, Cavrois E, Marchese E, Ferrara P, Kaghad M, Dumont X, Lupker J.

Gene. 1991 Jan 15;97(2):253-8.

PMID:
1999289
9.

Characterization of recombinant glycosylated human interleukin 2 produced by a recombinant plasmid transformed CHO cell line.

Ferrara P, Pecceu F, Marchese E, Vita N, Roskam W, Lupker J.

FEBS Lett. 1987 Dec 21;226(1):47-52.

10.

Supplemental Content

Loading ...
Support Center